Urticaria Factitia (Factitious Hives) – A Complete Patient Guide

Overview

Urticaria factitia, also known as factitious urticaria or self‑induced hives, is a form of chronic urticaria that occurs when a person deliberately introduces a physical or chemical irritant into the skin, causing wheals (hives) that look like typical allergic hives. Unlike most urticaria, the trigger is intentional rather than an immune‑mediated reaction.

Although exact numbers are hard to capture—because patients may conceal the behavior—studies suggest that factitious skin disorders represent 5–10 % of all chronic urticaria cases seen in dermatology and allergy clinics.^{[1] Mayo Clinic} The condition can affect anyone but is most frequently reported in:

• Adolescents and young adults (15‑35 years)
• Individuals with a history of psychiatric disorders (e.g., anxiety, depression, borderline personality disorder)
• Patients with chronic pain or a desire for medical attention (“secondary gain”)

Symptoms

Urticaria factitia mimics ordinary hives, but certain clues point to self‑induction. Typical symptoms include:

Skin manifestations

• Wheals (hives): Raised, erythematous, itchy plaques that appear suddenly and may vary in size from a few millimetres to several centimetres.
• Dermographism: Linear or streaky lesions that follow the pattern of scratching, rubbing, or applying a substance.
• Hyperpigmented or excoriated lesions: Chronic scratching can lead to darkened spots or scabs.
• Location pattern: Frequently seen on accessible sites – forearms, hands, face, neck, and trunk.

Associated symptoms

• Pruritus (intense itching) – often described as “burning” or “stinging”.
• Burning sensation after contact with a chemical irritant (e.g., perfume, cleaning agents).
• Intermittent swelling (angio‑edema) in lips or eyelids if the irritant spreads.
• Psychological distress – frustration, anxiety, or depression related to the skin appearance.

Causes and Risk Factors

Urticaria factitia is **behaviorally induced**. The underlying cause is not an allergic antibody response, but the intentional application of a trigger. Common methods include:

• Applying topical irritants (e.g., epoxy resin, nail polish remover, essential oils, or even household detergents).
• Mechanical irritation—scratching, rubbing, or using a rough object to produce a rash.
• Injection of substances (rare) such as saline or saline with a preservative.

Risk factors

• Psychiatric comorbidities: Mood disorders, personality disorders, or factitious disorder imposed on self (formerly Munchausen syndrome).
• History of chronic skin disease: Prior atopic dermatitis, psoriasis, or chronic urticaria can predispose.
• Social or occupational stressors: Desire for attention, sympathy, or time off work.
• Access to irritants: Occupations involving chemicals (e.g., cosmetology, cleaning) increase opportunity.

Diagnosis

Diagnosing urticaria factitia requires a careful blend of clinical observation, patient history, and exclusion of other causes. The steps typically include:

1. Detailed history and physical exam

• Ask about onset, pattern, and any known triggers.
• Note lesion distribution—symmetrical and limited to reachable areas raises suspicion.
• Observe for signs of manipulation (e.g., excoriations, linear scratches).

2. Laboratory work‑up (to rule out other urticarias)

• Complete blood count (CBC) – look for eosinophilia.
• Serum tryptase – elevated in mast cell activation disorders.
• Allergy testing (skin prick or specific IgE) – usually negative in factitious cases.

3. Provocation/Challenge testing (used cautiously)

If a specific irritant is suspected, a dermatologist may apply a small amount to a controlled skin area under observation. A positive reaction that replicates the patient’s lesions supports the diagnosis.

4. Psychiatric assessment

Referral to a mental‑health professional is essential to identify underlying factitious or obsessive‑compulsive behaviours. The DSM‑5 criteria for factitious disorder can guide evaluation.^{[2] American Psychiatric Association}

5. Differential diagnosis

Key conditions to exclude include:

• Acute or chronic spontaneous urticaria
• Physical urticarias (e.g., dermographism, pressure urticaria)
• Contact dermatitis
• Vasculitic lesions

Treatment Options

Management tackles two fronts: **skin symptom control** and **underlying psychosocial drivers**.

1. Pharmacologic therapy for hives

• Second‑generation antihistamines (cetirizine, loratadine, fexofenadine) – first‑line; can be up‑titrated to 2–4 × the standard dose if needed.^{[3] American Academy of Dermatology}
• H1‑H2 blocker combinations (cetirizine + ranitidine) – useful for refractory cases.
• Systemic corticosteroids (prednisone 10–30 mg daily) – short courses (≤7 days) for severe flares, but avoid long‑term use.
• Biologic agents – Omalizumab (anti‑IgE) has shown benefit in chronic urticaria unresponsive to antihistamines; limited data in factitious cases but may help if an autoimmune component co‑exists.

2. Dermatologic procedures

• Topical steroids (low‑to‑mid potency) for localized erythema.
• Barrier creams (zinc oxide, petrolatum) to protect irritated skin.

3. Psychological and behavioural interventions

• Cognitive‑behavioral therapy (CBT): Helps patients recognize triggers, develop coping skills, and reduce self‑injurious behaviour.
• Dialectical behavior therapy (DBT): Particularly useful for borderline personality disorder.
• Medication for underlying psychiatric illness: Selective serotonin reuptake inhibitors (SSRIs) for depression/anxiety; antipsychotics if delusional components are present.

4. Education and monitoring

Providing clear explanations that the skin changes are self‑inflicted, not contagious or life‑threatening, reduces shame and encourages collaboration.

Living with Urticaria Factitia

Long‑term quality of life improves when patients combine medical treatment with behavioural strategies. Practical tips include:

• Keep a symptom diary: Record the time of flare, location, suspected trigger, stress level, and medication taken. Patterns often emerge.
• Skin care routine: Use fragrance‑free moisturizers twice daily; avoid hot showers that can exacerbate itching.
• Identify and remove easy irritants: Store chemicals out of reach, replace scented soaps with mild, hypoallergenic options.
• Stress‑management techniques: Deep‑breathing, meditation, or light exercise can lower the urge to self‑induce.
• Support network: Join a chronic‑skin‑condition support group (online or in‑person) to share coping strategies.
• Follow‑up schedule: Regular (every 4–6 weeks) visits with dermatology and psychiatry to adjust treatment and reinforce goals.

Prevention

Because the core issue is behavioural, prevention focuses on reducing access to triggers and addressing psychosocial drivers.

• Secure potentially irritating substances (e.g., keep nail‑polish remover, bleach, essential oils locked away).
• Use “safe‑skin” kits that contain only mild, non‑irritating products.
• Engage in therapy early if you notice an urge to scratch or apply substances to the skin.
• Educate family members or roommates about the condition so they can help monitor for self‑induced lesions.
• Maintain a balanced lifestyle—adequate sleep, nutrition, and regular physical activity—to lower stress thresholds.

Complications

If left untreated, urticaria factitia can lead to several medical and psychosocial complications:

• Chronic skin changes: Lichenification (thickened skin), hyperpigmentation, and scarring.
• Secondary infection: Excoriated lesions can become colonised with Staphylococcus aureus or Streptococcus, requiring antibiotics.
• Allergic sensitisation: Repeated exposure to chemicals may sensitize the skin, leading to true contact dermatitis.
• Mental‑health decline: Persistent shame, isolation, or worsening depression/anxiety.
• Medication overuse: Frequent reliance on high‑dose antihistamines or steroids increases risk of side effects (e.g., sedation, hypertension, osteoporosis).

When to Seek Emergency Care

Sources: [1] Mayo Clinic. “Factitious Skin Disorders.” 2023. [2] American Psychiatric Association. DSM‑5® (2013). [3] American Academy of Dermatology. “Urticaria: Diagnosis and Management.” 2022. CDC, NIH, WHO, and Cleveland Clinic guidelines were consulted for general urticaria and antihistamine safety data.